Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study

Swaminathan P. Iyer, Bradley M. Haverkos, Weiyun Z. Ai et al.|Haematologica|2023

Cited by 24